首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Phenolic enriched fraction of Clerodendrum glandulosum Lindl. leaf extract ameliorates hyperglycemia and oxidative stress in streptozotocin-nicotinamide induced diabetic rats 叶提取物中富含酚的部分可改善链脲佐菌素-烟酰胺诱导的糖尿病大鼠的高血糖和氧化应激症状
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100906
Puspanjali Khound , Prashanta Kumar Deb , Swarnali Bhattacharjee , Karla Damián Medina , Partha Pratim Sarma , Biswatrish Sarkar , Rajlakshmi Devi

Background

Clerodendrum glandulosum Lindl. is an important ethnomedicinal shrub of Northeast India, used by traditional healers to control various ailments like diabetes, hypertension, arthritis, etc.

Objectives

The present study was conducted to explore the anti-hyperglycemic and antioxidative effects of the polyphenol-rich fraction (PRF) of C. glandulosum leaf extract and identification of its major bioactive compounds. Further, an in-silico molecular docking study was also performed to understand the molecular interactions of the identified major compounds with some target proteins associated with diabetic complications.

Materials and methods

PRF was purified from the hydromethanolic (80% MeOH) extract of leaves and subjected to assessment of in-vitro antioxidant and anti-diabetic properties. It was also subjected to evaluate the ameliorative effect during streptozotocin-nicotinamide-induced hyperglycemia in Wistar albino rats. An in-silico molecular docking study was also performed to complement the in-vitro/in-vivo studies.

Results

Chemical analysis of PRF showed the presence of phenolics like caffeic acid, verbascoside, isoverbascoside, and apigenin, of which verbascoside (598.14 ± 1.24 mg/g) was found to be the principal compound. In-vitro studies showed potent antioxidant (IC50 of DPPH:32.45 ± 2.16 μg/mL; ABTS:39.08 ± 0.53 μg/mL) properties and excellent aldose reductase inhibition potential (IC50 2.18 ± 0.10 μg/mL). Treatment with PRF showed reduced blood glucose levels and increased plasma insulin levels. The results also indicate an improvement of endogenous antioxidants and suppression of inflammatory cytokines (IL-6 and TNF-α) comparable to the standard. Molecular docking studies predicted promising interactions between the identified molecules and the crucial amino acid residues of the enzymes involved in the development of hyperglycemia.

Conclusion

This study revealed the antihyperglycemic and antioxidant potential of partially purified fraction PRF of C. glandulosum leaves.

背景Clerodendrum glandulosum Lindl.是印度东北部一种重要的民族药用灌木,被传统医学家用于控制糖尿病、高血压、关节炎等各种疾病。此外,还进行了室内分子对接研究,以了解已确定的主要化合物与一些与糖尿病并发症相关的靶蛋白之间的分子相互作用。材料和方法从叶的水乙醇(80% MeOH)提取物中纯化出富含多酚的馏分(PRF),并对其进行体外抗氧化和抗糖尿病特性评估。此外,还对链脲佐菌素-烟酰胺诱导的 Wistar 白化大鼠高血糖症的改善效果进行了评估。结果PRF的化学分析显示其含有咖啡酸、马鞭草苷、异马鞭草苷和芹菜素等酚类化合物,其中马鞭草苷(598.14 ± 1.24 mg/g)是主要化合物。体外研究显示,PRF 具有很强的抗氧化性(DPPH 的 IC50:32.45 ± 2.16 μg/mL;ABTS:39.08 ± 0.53 μg/mL)和出色的醛糖还原酶抑制潜力(IC50 2.18 ± 0.10 μg/mL)。使用 PRF 治疗后,血糖水平降低,血浆胰岛素水平升高。结果还表明,内源性抗氧化剂和炎症细胞因子(IL-6 和 TNF-α)的抑制作用与标准相当。分子对接研究预测了已鉴定分子与参与高血糖发生的酶的关键氨基酸残基之间的相互作用。
{"title":"Phenolic enriched fraction of Clerodendrum glandulosum Lindl. leaf extract ameliorates hyperglycemia and oxidative stress in streptozotocin-nicotinamide induced diabetic rats","authors":"Puspanjali Khound ,&nbsp;Prashanta Kumar Deb ,&nbsp;Swarnali Bhattacharjee ,&nbsp;Karla Damián Medina ,&nbsp;Partha Pratim Sarma ,&nbsp;Biswatrish Sarkar ,&nbsp;Rajlakshmi Devi","doi":"10.1016/j.jaim.2024.100906","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100906","url":null,"abstract":"<div><h3>Background</h3><p><em>Clerodendrum glandulosum</em> Lindl. is an important ethnomedicinal shrub of Northeast India, used by traditional healers to control various ailments like diabetes, hypertension, arthritis, etc.</p></div><div><h3>Objectives</h3><p>The present study was conducted to explore the anti-hyperglycemic and antioxidative effects of the polyphenol-rich fraction (PRF) of <em>C. glandulosum</em> leaf extract and identification of its major bioactive compounds. Further, an <em>in-silico</em> molecular docking study was also performed to understand the molecular interactions of the identified major compounds with some target proteins associated with diabetic complications.</p></div><div><h3>Materials and methods</h3><p>PRF was purified from the hydromethanolic (80% MeOH) extract of leaves and subjected to assessment of <em>in-vitro</em> antioxidant and anti-diabetic properties. It was also subjected to evaluate the ameliorative effect during streptozotocin-nicotinamide-induced hyperglycemia in Wistar albino rats. An <em>in-silico</em> molecular docking study was also performed to complement the <em>in-vitro/in-vivo</em> studies.</p></div><div><h3>Results</h3><p>Chemical analysis of PRF showed the presence of phenolics like caffeic acid, verbascoside, isoverbascoside, and apigenin, of which verbascoside (598.14 ± 1.24 mg/g) was found to be the principal compound. <em>In-vitro</em> studies showed potent antioxidant (IC<sub>50</sub> of DPPH:32.45 ± 2.16 μg/mL; ABTS:39.08 ± 0.53 μg/mL) properties and excellent aldose reductase inhibition potential (IC<sub>50</sub> 2.18 ± 0.10 μg/mL). Treatment with PRF showed reduced blood glucose levels and increased plasma insulin levels. The results also indicate an improvement of endogenous antioxidants and suppression of inflammatory cytokines (IL-6 and TNF-α) comparable to the standard. Molecular docking studies predicted promising interactions between the identified molecules and the crucial amino acid residues of the enzymes involved in the development of hyperglycemia.</p></div><div><h3>Conclusion</h3><p>This study revealed the antihyperglycemic and antioxidant potential of partially purified fraction PRF of <em>C. glandulosum</em> leaves.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100906"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000214/pdfft?md5=ad4b4b22d5acb10dc7e9cc7c918f5c81&pid=1-s2.0-S0975947624000214-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140951718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis 对遗传性胰腺炎患者采用阿育吠陀治疗方案效果的观察研究。
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100913
Vaidya Balendu Prakash , Shikha Prakash , Neha Negi , Sneha Tiwari Sati

Background

Hereditary pancreatitis (HP) is a chronic and recurrent inflammatory disorder caused by genetic abnormalities, often accompanied by severe symptoms and complications. Conventional treatments offer limited relief but fail to halt disease progression. An Ayurvedic Treatment Protocol has been reported to be effective in treating various types of pancreatitis.

Objectives

This observational clinical study is aimed at assessing the efficacy of a year long Ayurvedic treatment protocol (ATP) in mitigating attack frequency and intensity in Hereditary Pancreatitis patients.

Materials & Methods

The study enrolled 151 patients across diverse age groups and genders, subjecting them to a comprehensive Ayurvedic treatment protocol at a specialized center. The protocol incorporated Metal-Based Ayurvedic Formulation (MBAF) named Amar, alongside supportive Ayurvedic compounds and dietary adjustments. Patients underwent pre- and post-treatment evaluations involving interviews, medical records, blood tests, radiological imaging, and symptom assessments. Notably, pancreatic enzyme use was discontinued prior to initiating Ayurvedic treatment.

Results

Among 151 patients, 88 completed the year long ATP, resulting in significant enhancement of their quality of life. There was a marked 98.7% reduction in emergency hospitalizations and a notable 92.8% decrease in attack frequency (p < 0.0001). Radiological assessments indicated pancreatic health stabilization, while no adverse effects were reported, highlighting the intervention's safety and tolerability.

Conclusion

The study furnishes promising evidence supporting the efficacy and safety of ATP, especially the MBAF, in managing Hereditary Pancreatitis. The observed decline in attack frequency, absence of adverse effects, and stabilization of pancreatic health underscore the potential of Ayurvedic medicine. Subsequent research, including randomized controlled trials, is warranted to substantiate these findings and elucidate underlying mechanisms.

背景:遗传性胰腺炎(HP)是一种由基因异常引起的慢性、复发性炎症性疾病,通常伴有严重的症状和并发症。传统治疗方法可提供有限的缓解,但无法阻止疾病的发展。据报道,阿育吠陀治疗方案可有效治疗各种类型的胰腺炎:这项观察性临床研究旨在评估为期一年的阿育吠陀治疗方案(ATP)在减轻遗传性胰腺炎患者发作频率和强度方面的疗效:该研究招募了 151 名不同年龄段和性别的患者,在一家专业中心对他们进行了全面的阿育吠陀治疗方案。该方案包括名为 "阿马尔 "的金属阿育吠陀配方(MBAF),以及辅助性阿育吠陀化合物和饮食调整。患者接受了治疗前后的评估,包括访谈、病历、血液化验、放射成像和症状评估。值得注意的是,在开始阿育吠陀疗法之前,患者已停止使用胰酶:结果:在 151 名患者中,88 人完成了为期一年的 ATP,生活质量显著提高。急诊住院率明显降低了 98.7%,发病频率明显降低了 92.8%(p 结论:该研究为支持阿育吠陀疗法提供了有希望的证据:这项研究为 ATP(尤其是 MBAF)治疗遗传性胰腺炎的有效性和安全性提供了有力的证据。观察到的发病频率下降、无不良反应以及胰腺健康的稳定都凸显了阿育吠陀医学的潜力。后续研究,包括随机对照试验,需要证实这些发现并阐明其潜在机制。
{"title":"Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis","authors":"Vaidya Balendu Prakash ,&nbsp;Shikha Prakash ,&nbsp;Neha Negi ,&nbsp;Sneha Tiwari Sati","doi":"10.1016/j.jaim.2024.100913","DOIUrl":"10.1016/j.jaim.2024.100913","url":null,"abstract":"<div><h3>Background</h3><p>Hereditary pancreatitis (HP) is a chronic and recurrent inflammatory disorder caused by genetic abnormalities, often accompanied by severe symptoms and complications. Conventional treatments offer limited relief but fail to halt disease progression. An Ayurvedic Treatment Protocol has been reported to be effective in treating various types of pancreatitis.</p></div><div><h3>Objectives</h3><p>This observational clinical study is aimed at assessing the efficacy of a year long Ayurvedic treatment protocol (ATP) in mitigating attack frequency and intensity in Hereditary Pancreatitis patients.</p></div><div><h3>Materials &amp; Methods</h3><p>The study enrolled 151 patients across diverse age groups and genders, subjecting them to a comprehensive Ayurvedic treatment protocol at a specialized center. The protocol incorporated Metal-Based Ayurvedic Formulation (MBAF) named Amar, alongside supportive Ayurvedic compounds and dietary adjustments. Patients underwent pre- and post-treatment evaluations involving interviews, medical records, blood tests, radiological imaging, and symptom assessments. Notably, pancreatic enzyme use was discontinued prior to initiating Ayurvedic treatment.</p></div><div><h3>Results</h3><p>Among 151 patients, 88 completed the year long ATP, resulting in significant enhancement of their quality of life. There was a marked 98.7% reduction in emergency hospitalizations and a notable 92.8% decrease in attack frequency (p &lt; 0.0001). Radiological assessments indicated pancreatic health stabilization, while no adverse effects were reported, highlighting the intervention's safety and tolerability.</p></div><div><h3>Conclusion</h3><p>The study furnishes promising evidence supporting the efficacy and safety of ATP, especially the MBAF, in managing Hereditary Pancreatitis. The observed decline in attack frequency, absence of adverse effects, and stabilization of pancreatic health underscore the potential of Ayurvedic medicine. Subsequent research, including randomized controlled trials, is warranted to substantiate these findings and elucidate underlying mechanisms.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100913"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000287/pdfft?md5=f9c1bd3da42fb7a3d9123b1594c35b1d&pid=1-s2.0-S0975947624000287-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141064961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Achieving holistic health through ayurveda along with advanced technologies: A conference report 通过阿育吠陀和先进技术实现整体健康:会议报告
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100967
Ashwani Kumar, Vedpriya Arya
{"title":"Achieving holistic health through ayurveda along with advanced technologies: A conference report","authors":"Ashwani Kumar,&nbsp;Vedpriya Arya","doi":"10.1016/j.jaim.2024.100967","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100967","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100967"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000822/pdfft?md5=9ef57a2b72febf5327498727a3726c43&pid=1-s2.0-S0975947624000822-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141156251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive review on technological advancements for sensor-based Nadi Pariksha: An ancient Indian science for human health diagnosis 全面回顾基于传感器的 Nadi Pariksha 的技术进步:印度古代人体健康诊断科学
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100958
Mrunal Fatangare, Sukhada Bhingarkar

Nadi Pariksha is a significant, rather symbolic term for Ayurveda. Ancient Ayurvedic literature has prominently stated its importance in the judgment of Tridoshas (Vata, Pitta, and Kapha) which are the base of ailment diagnosis and prediction. The knowledge about Nadi Pariksha is uncovered in various ancient Ayurvedic literature like Ravansamhita, Bhavprakash, Nadivigyan by Kanad, Sharangdhar, and Yogratnakar. The various Nadi parameters are indicative of the diagnosis of diseases. These techniques were used as popular diagnostic tools in Indian culture from ancient days. Still, nowadays, these are not being used explicitly due to the lack of expertise, so it is necessary to establish their results once gained so that they can be used along with technical aspects in today's era. Ayurveda believes that all the elements of the Universe are present in any human body in minute, proportionate quantity, and the Nadi represents these elements, that is, Vata, Pitta, and Kapha (VPK). To facilitate the Nadi Pariksha using appropriate sensors may help the Ayurveda practitioners diagnose Prakriti and predict some diseases, making the Nadi Pariksha more reliable and faster.

This review paper lists, 2 books and 67 research papers, mostly from countries like India, China, Japan, Korea, etc., from various reputed databases. The review primarily concentrates on six research themes: sensors and devices used for Nadi signal acquisition, signal pre-processing methods, feature extraction methods, feature selection approaches, classification practices, diseases diagnosed, and results attained. The paper also reviews the challenges in implementing the automated Nadi Pariksha with technological aid, which is a necessity of this period and is a very vibrant research arena. Yet significant work remains to be done, like bridging the gaps between technical and commercial development, and the procedure standardization is also required.

Nadi Pariksha 在阿育吠陀学中是一个重要的象征性术语。古代阿育吠陀文献突出强调了它在三性(Vata、Pitta 和 Kapha)判断中的重要性,而三性是疾病诊断和预测的基础。有关 Nadi Pariksha 的知识见于各种古代阿育吠陀文献,如 Ravansamhita、Bhavprakash、Kanad 的 Nadivigyan、Sharangdhar 和 Yogratnakar。各种纳迪参数是诊断疾病的指标。这些技术自古以来就是印度文化中常用的诊断工具。但如今,由于缺乏专业知识,这些技术并没有被明确使用,因此有必要在获得这些技术的结果后,将其与技术方面一起用于当今时代。阿育吠陀认为,宇宙中的所有元素都以微小的比例存在于人体中,而 Nadi 代表了这些元素,即 Vata、Pitta 和 Kapha(VPK)。为了方便Nadi Pariksha,使用适当的传感器可以帮助阿育吠陀医师诊断Prakriti和预测一些疾病,使Nadi Pariksha更可靠、更快速。这篇综述论文列出了2本书和67篇研究论文,大部分来自印度、中国、日本、韩国等国家,来自各种知名数据库。综述主要集中在六个研究主题上:用于采集纳迪信号的传感器和设备、信号预处理方法、特征提取方法、特征选择方法、分类实践、疾病诊断和取得的成果。论文还回顾了在技术辅助下实现自动纳迪帕里克沙所面临的挑战,这是当前的必然选择,也是一个非常活跃的研究领域。然而,仍有大量工作要做,如弥合技术和商业发展之间的差距,以及程序标准化也是必需的。
{"title":"A comprehensive review on technological advancements for sensor-based Nadi Pariksha: An ancient Indian science for human health diagnosis","authors":"Mrunal Fatangare,&nbsp;Sukhada Bhingarkar","doi":"10.1016/j.jaim.2024.100958","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100958","url":null,"abstract":"<div><p><em>Nadi Pariksha</em> is a significant, rather symbolic term for Ayurveda. Ancient Ayurvedic literature has prominently stated its importance in the judgment of <em>Tridosha</em>s (<em>Vata</em>, <em>Pitta</em>, and <em>Kapha</em>) which are the base of ailment diagnosis and prediction. The knowledge about <em>Nadi Pariksha</em> is uncovered in various ancient Ayurvedic literature like Ravansamhita, Bhavprakash, <em>Nadi</em>vigyan by Kanad, Sharangdhar, and Yogratnakar. The various <em>Nadi</em> parameters are indicative of the diagnosis of diseases. These techniques were used as popular diagnostic tools in Indian culture from ancient days. Still, nowadays, these are not being used explicitly due to the lack of expertise, so it is necessary to establish their results once gained so that they can be used along with technical aspects in today's era. Ayurveda believes that all the elements of the Universe are present in any human body in minute, proportionate quantity, and the <em>Nadi</em> represents these elements, that is, <em>Vata</em>, <em>Pitta</em>, and <em>Kapha</em> (VPK). To facilitate the <em>Nadi Pariksha</em> using appropriate sensors may help the Ayurveda practitioners diagnose Prakriti and predict some diseases, making the <em>Nadi Pariksha</em> more reliable and faster.</p><p>This review paper lists, 2 books and 67 research papers, mostly from countries like India, China, Japan, Korea, etc., from various reputed databases. The review primarily concentrates on six research themes: sensors and devices used for Nadi signal acquisition, signal pre-processing methods, feature extraction methods, feature selection approaches, classification practices, diseases diagnosed, and results attained. The paper also reviews the challenges in implementing the automated Nadi Pariksha with technological aid, which is a necessity of this period and is a very vibrant research arena. Yet significant work remains to be done, like bridging the gaps between technical and commercial development, and the procedure standardization is also required.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100958"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000731/pdfft?md5=95a6fe000a608e29cbe842972898f60f&pid=1-s2.0-S0975947624000731-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141164648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of dengue haemorrhagic fever with menorrhagia: A case report 阿育吠陀疗法治疗登革出血热伴月经过多:病例报告
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100923
Archana Sreedharan , Vijaya lekshmi R , Vishnu B

Dengue fever is one of the most common tropical disease affecting humans. Symptomatic dengue infection causes a wide range of clinical manifestations from mild dengue fever to potentially fatal disease such as DHF or DSS. Menorrhagia is rarely presented as a symptom in females with DHF. It is often unnoticed in adolescents who has history of irregular menstruation especially in case of PCOS. This case discusses about an adolescent girl who presented with heavy menstrual bleeding, reddish discolouration of urine, severe abdominal pain, generalised body ache, mild head ache, nausea and fever along with a history of irregular menstruation. Dengue fever along with covid-19 was suspected due to the presentation and the patient revealed a travel history to relative's house. Ayurvedic medicines were administered according to patient's condition. The disease was confirmed as Dengue Haemorrhagic fever by Dengue IgM antibody, Dengue IgG Antibody, NS1 Ag and low platelet count, along with negative RT-PCR for Covid-19. This case serves as a valuable case study in DHF, which can be overlooked by Gynaecologists due to its co-presentation with menstruation, especially in patients with a history of irregular menstruation due to PCOS. Further more this case demonstrates the efficacy of simple, cost effective Ayurvedic interventions, which can be successfully utilized in fatal diseases like DHF with proper monitoring and follow up.

登革热是影响人类的最常见热带疾病之一。无症状的登革热感染会导致多种临床表现,从轻微的登革热到可能致命的疾病,如登革热性休克或登革热热性病变。女性登革热患者很少出现月经过多的症状。有月经不调病史的青少年,尤其是患有多囊卵巢综合症的青少年,月经过多往往不被注意。本病例讨论的是一名少女,她出现大量月经出血、尿液变红、剧烈腹痛、全身疼痛、轻微头痛、恶心和发热,并伴有月经不调病史。根据患者的症状,怀疑其患有登革热和covid-19,并且患者曾有到亲戚家旅行的经历。医生根据患者的病情给他服用了阿育吠陀药物。通过登革热 IgM 抗体、登革热 IgG 抗体、NS1 Ag 和低血小板计数以及 Covid-19 RT-PCR 阴性检测,证实该病为登革出血热。本病例是登革出血热的一个有价值的病例研究,由于登革出血热与月经同时出现,特别是在因多囊卵巢综合征而有月经不调病史的患者中,可能会被妇科医生忽视。此外,该病例还证明了简单、经济有效的阿育吠陀疗法干预措施的功效,只要进行适当的监测和随访,就能成功地治疗像 DHF 这样的致命疾病。
{"title":"Ayurvedic management of dengue haemorrhagic fever with menorrhagia: A case report","authors":"Archana Sreedharan ,&nbsp;Vijaya lekshmi R ,&nbsp;Vishnu B","doi":"10.1016/j.jaim.2024.100923","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100923","url":null,"abstract":"<div><p>Dengue fever is one of the most common tropical disease affecting humans. Symptomatic dengue infection causes a wide range of clinical manifestations from mild dengue fever to potentially fatal disease such as DHF or DSS. Menorrhagia is rarely presented as a symptom in females with DHF. It is often unnoticed in adolescents who has history of irregular menstruation especially in case of PCOS. This case discusses about an adolescent girl who presented with heavy menstrual bleeding, reddish discolouration of urine, severe abdominal pain, generalised body ache, mild head ache, nausea and fever along with a history of irregular menstruation. Dengue fever along with covid-19 was suspected due to the presentation and the patient revealed a travel history to relative's house. Ayurvedic medicines were administered according to patient's condition. The disease was confirmed as Dengue Haemorrhagic fever by Dengue IgM antibody, Dengue IgG Antibody, NS1 Ag and low platelet count, along with negative RT-PCR for Covid-19. This case serves as a valuable case study in DHF, which can be overlooked by Gynaecologists due to its co-presentation with menstruation, especially in patients with a history of irregular menstruation due to PCOS. Further more this case demonstrates the efficacy of simple, cost effective <em>Ayurvedic</em> interventions, which can be successfully utilized in fatal diseases like DHF with proper monitoring and follow up.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100923"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S097594762400038X/pdfft?md5=bd1565ef871160a789b9cfe766b86e8e&pid=1-s2.0-S097594762400038X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141095652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanism of antibacterial activity of diallyl sulfide against Bacillus cereus 二烯丙基硫醚对蜡样芽孢杆菌的抗菌作用机理。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100951
Manish Kumar Manjhi , Prachi Chauhan , Chandrama Prakash Upadhyaya , Anirudh K. Singh , Rajaneesh Anupam

World health organization (WHO) recognizes antimicrobial resistance as a silent pandemic. It is estimated that 10 million deaths will occur annually due to antimicrobial resistant infections by 2050. Phytochemicals exhibit activity against drug resistant bacteria, offering potential for developing novel antibacterial agents. Garlic organosulphur compounds exhibit potent activity against a variety of drug-resistant bacteria. Identifying their mechanism of action is critical to assess their potential to be developed as novel antibacterial agents. Diallyl sulfide (DAS) is a component of garlic essential oil with antibacterial activity. In this study antibacterial activity of DAS was investigated against Bacillus cereus, a common foodborne pathogen. DAS exhibited activity against B. cereus with a minimum inhibitory concentration (MIC) of 54.75 mM. The presence of DAS significantly reduced the growth of B. cereus. The study also investigated the mechanism of antibacterial activity of DAS against B. cereus. Treating B. cereus with sub-MIC and MIC concentration of DAS resulted in a dose and time-dependent leakage of intracellular proteins. The protein leakage was enhanced at acidic pH. Scanning electron microscopy (SEM) of B. cereus treated with DAS showed deformation in the cell membrane. Thus, the data indicate that DAS exerts its antibacterial activity by compromising the membrane integrity of B. cereus. The study demonstrates DAS could be used to control B. cereus infections. The findings indicate that DAS has a membrane altering activity, suggesting that development of resistance to this mechanism is less likely and the compound could be novel antibacterial or a good adjuvant for antibiotics.

世界卫生组织(WHO)认为抗菌药耐药性是一种无声的流行病。据估计,到 2050 年,每年将有 1000 万人死于抗菌药耐药性感染。植物化学物质对抗药性细菌具有活性,为开发新型抗菌剂提供了潜力。大蒜有机硫化合物对多种耐药细菌具有强效活性。确定其作用机制对于评估其作为新型抗菌剂的开发潜力至关重要。二烯丙基硫醚(DAS)是大蒜精油中具有抗菌活性的一种成分。本研究调查了 DAS 对蜡样芽孢杆菌(一种常见的食源性病原体)的抗菌活性。DAS 对蜡样芽孢杆菌具有活性,最低抑菌浓度 (MIC) 为 54.75 mM。DAS 的存在大大减少了蜡样芽孢杆菌的生长。研究还探讨了 DAS 对蜡样芽孢杆菌的抗菌机制。用亚微克浓度和微克浓度的 DAS 处理蜡样芽孢杆菌会导致细胞内蛋白质的泄漏,而泄漏的剂量和时间与浓度有关。在酸性 pH 条件下,蛋白质的渗漏会增强。用 DAS 处理的蜡样芽孢杆菌的扫描电子显微镜(SEM)显示细胞膜变形。因此,这些数据表明 DAS 是通过破坏 B. cereus 细胞膜的完整性来发挥其抗菌活性的。该研究表明 DAS 可用于控制蜡样芽孢杆菌感染。研究结果表明,DAS 具有改变细胞膜的活性,这表明这种机制产生抗药性的可能性较小,而且该化合物可以成为新型抗菌剂或抗生素的良好辅助剂。
{"title":"Mechanism of antibacterial activity of diallyl sulfide against Bacillus cereus","authors":"Manish Kumar Manjhi ,&nbsp;Prachi Chauhan ,&nbsp;Chandrama Prakash Upadhyaya ,&nbsp;Anirudh K. Singh ,&nbsp;Rajaneesh Anupam","doi":"10.1016/j.jaim.2024.100951","DOIUrl":"10.1016/j.jaim.2024.100951","url":null,"abstract":"<div><p>World health organization (WHO) recognizes antimicrobial resistance as a silent pandemic. It is estimated that 10 million deaths will occur annually due to antimicrobial resistant infections by 2050. Phytochemicals exhibit activity against drug resistant bacteria, offering potential for developing novel antibacterial agents. Garlic organosulphur compounds exhibit potent activity against a variety of drug-resistant bacteria. Identifying their mechanism of action is critical to assess their potential to be developed as novel antibacterial agents. Diallyl sulfide (DAS) is a component of garlic essential oil with antibacterial activity. In this study antibacterial activity of DAS was investigated against <em>Bacillus cereus</em>, a common foodborne pathogen. DAS exhibited activity against <em>B. cereus</em> with a minimum inhibitory concentration (MIC) of 54.75 mM. The presence of DAS significantly reduced the growth of <em>B. cereus</em>. The study also investigated the mechanism of antibacterial activity of DAS against <em>B. cereus</em>. Treating <em>B. cereus</em> with sub-MIC and MIC concentration of DAS resulted in a dose and time-dependent leakage of intracellular proteins. The protein leakage was enhanced at acidic pH. Scanning electron microscopy (SEM) of <em>B. cereus</em> treated with DAS showed deformation in the cell membrane. Thus, the data indicate that DAS exerts its antibacterial activity by compromising the membrane integrity of <em>B. cereus</em>. The study demonstrates DAS could be used to control <em>B. cereus</em> infections. The findings indicate that DAS has a membrane altering activity, suggesting that development of resistance to this mechanism is less likely and the compound could be novel antibacterial or a good adjuvant for antibiotics.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100951"},"PeriodicalIF":1.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000664/pdfft?md5=69d94a21feeb48cba749fa315d825b17&pid=1-s2.0-S0975947624000664-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141317444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the efficacy of Agnikarma with therapeutic ultrasound in the management of tennis elbow - A randomised controlled preliminary study 比较阿尼卡尔玛与治疗性超声波在治疗网球肘方面的疗效--随机对照初步研究
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100898
R Sreelekshmi, Shaithya Raj, P N Rajeshwari, Rabinarayan Tripathy

Background

Tennis elbow is a common musculoskeletal disease of elbow and causes restricted movement of forearm. Various treatment modalities like NSAID, corticosteroid injection, counter bracing, physiotherapy, surgery etc are available but safety and efficacy of one treatment over another is under research. Ayurveda classifies this condition as Snayugata vata. According to Sushruta, Agnikarma (thermal cautery) is the one among the treatment modalities for Snayugata vata. Previously published randomised controlled trials have shown that therapeutic ultrasound is safe and effective for tennis elbow. However, the comparative efficacy of these two treatment modalities is unknown.

Objective

This study compares the effects of Agnikarma (AGK) with Therapeutic Ultrasound (TUS) in reducing pain, tenderness and restores the ability to do various tasks.

Materials and methods

A total of 30 patients were enrolled in the study as an open-label, double-armed, prospectively designed comparative clinical study, with 15 patients in each group. Group AGK received two sittings of Agnikarma and Group TUS received therapeutic ultrasound. To analyze the patients, three outcome measures were adopted: pain intensity, assessed with a Numerical Pain Rating Scale, tenderness – Grade 0 to Grade 4 (mentioned in Hutchinson's clinical methods) and pain and functional Disability assessed with the Patient Rated Tennis Elbow Evaluation (PRTEE) questionnaire. Assessment was done on 0th, 8th, 15th, 30th and 60th day.

Result

Tennis elbow can be effectively treated with AGK and TUS. (p < 0.001 for pain, tenderness and PRTEE). While comparing between the groups, on 8th day and 15th day statistically significant difference in pain and PRTEE (p < 0.05) was noted between AGK and TUS groups. Agnikarma showed better results than therapeutic ultrasound in pain management and showed an improved quality of life from 8th day onwards and for a period up to 2 months.

Conclusion

Both Agnikarma and therapeutic ultrasound have roles in the management of tennis elbow. However, starting on the 8th day and continuing for up to 2 months, Agnikarma showed a significant benefit in pain management and improved status for quality of life.

背景网球肘是一种常见的肘部肌肉骨骼疾病,会导致前臂活动受限。目前有多种治疗方法,如非甾体抗炎药、皮质类固醇注射、反向支撑、物理疗法、手术等,但各种治疗方法的安全性和有效性仍在研究之中。阿育吠陀将这种疾病归类为 "Snayugata vata"。根据 Sushruta 的说法,Agnikarma(热烧灼法)是治疗 Snayugata vata 的方法之一。之前发表的随机对照试验表明,超声波治疗对网球肘安全有效。本研究比较了 Agnikarma(AGK)和治疗性超声波(TUS)在减轻疼痛、触痛和恢复各种工作能力方面的效果。AGK 组接受两次阿尼克玛治疗,TUS 组接受超声波治疗。为了对患者进行分析,我们采用了三种结果测量方法:疼痛强度(用数字疼痛分级量表评估)、触痛--0 至 4 级(Hutchinson 临床方法中提到)以及疼痛和功能障碍(用患者网球肘评估问卷评估)。评估在第 0 天、第 8 天、第 15 天、第 30 天和第 60 天进行。(疼痛、触痛和 PRTEE 均为 0.001。)在各组之间进行比较时,第 8 天和第 15 天,AGK 组和 TUS 组在疼痛和 PRTEE 方面存在显著统计学差异(p < 0.05)。在疼痛治疗方面,阿格尼卡玛的效果优于治疗性超声波,而且从第 8 天起,在长达 2 个月的时间里,阿格尼卡玛的生活质量得到了改善。然而,从第 8 天开始并持续 2 个月,阿格尼卡玛疗法在疼痛控制和改善生活质量方面显示出明显的优势。
{"title":"Comparing the efficacy of Agnikarma with therapeutic ultrasound in the management of tennis elbow - A randomised controlled preliminary study","authors":"R Sreelekshmi,&nbsp;Shaithya Raj,&nbsp;P N Rajeshwari,&nbsp;Rabinarayan Tripathy","doi":"10.1016/j.jaim.2024.100898","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100898","url":null,"abstract":"<div><h3>Background</h3><p>Tennis elbow is a common musculoskeletal disease of elbow and causes restricted movement of forearm. Various treatment modalities like NSAID, corticosteroid injection, counter bracing, physiotherapy, surgery etc are available but safety and efficacy of one treatment over another is under research. Ayurveda classifies this condition as <em>Snayugata vata.</em> According to Sushruta, <em>Agnikarma</em> (thermal cautery) is the one among the treatment modalities for <em>Snayugata vata.</em> Previously published randomised controlled trials have shown that therapeutic ultrasound is safe and effective for tennis elbow. However, the comparative efficacy of these two treatment modalities is unknown.</p></div><div><h3>Objective</h3><p>This study compares the effects of Agnikarma (AGK) with Therapeutic Ultrasound (TUS) in reducing pain, tenderness and restores the ability to do various tasks.</p></div><div><h3>Materials and methods</h3><p>A total of 30 patients were enrolled in the study as an open-label, double-armed, prospectively designed comparative clinical study, with 15 patients in each group. Group AGK received two sittings of Agnikarma and Group TUS received therapeutic ultrasound. To analyze the patients, three outcome measures were adopted: pain intensity, assessed with a Numerical Pain Rating Scale, tenderness – Grade 0 to Grade 4 (mentioned in Hutchinson's clinical methods) and pain and functional Disability assessed with the Patient Rated Tennis Elbow Evaluation (PRTEE) questionnaire. Assessment was done on 0<sup>th</sup>, 8<sup>th</sup>, 15<sup>th</sup>, 30<sup>th</sup> and 60<sup>th</sup> day.</p></div><div><h3>Result</h3><p>Tennis elbow can be effectively treated with AGK and TUS. (p &lt; 0.001 for pain, tenderness and PRTEE). While comparing between the groups, on 8<sup>th</sup> day and 15<sup>th</sup> day statistically significant difference in pain and PRTEE (p &lt; 0.05) was noted between AGK and TUS groups. Agnikarma showed better results than therapeutic ultrasound in pain management and showed an improved quality of life from 8<sup>th</sup> day onwards and for a period up to 2 months.</p></div><div><h3>Conclusion</h3><p>Both Agnikarma and therapeutic ultrasound have roles in the management of tennis elbow. However, starting on the 8<sup>th</sup> day and continuing for up to 2 months, Agnikarma showed a significant benefit in pain management and improved status for quality of life.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100898"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000135/pdfft?md5=c1509dd21a0a604471c478b3691451ef&pid=1-s2.0-S0975947624000135-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of epistemology and translation for health and integration: A commentary on the special issue ‘Integrative approaches to health’ 认识论和翻译对健康与整合的重要性:对 "综合保健方法 "特刊的评论。
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-05-01 DOI: 10.1016/j.jaim.2024.100924
John DH. Porter , Andrea Núñez Casal , Coll de Lima Hutchison , Mahesh Madhav Mathpati , The Kshoba Group

In this commentary on the J-AIM Special Issue 'Integrative Approaches to Health', we argue for plural narratives of health to balance and to reconnect human populations with their environments, to foster a renewed culture of health and wellbeing. Integration of our inner and outer ecosystems with pluralistic health systems requires ‘movement’ and ‘change’ and the special issue provides papers on integration and health from multiple disciplinary perspectives that study humans, non-human, animals, and plants in relation to clinical trials, individual and population studies and health systems. All these perspectives provide new insights to map integrative approaches in health, illness and wellbeing in times of the climate emergency.

To ameliorate the biomedical and biopharmaceutical industries 'medicalisation of life' as the hegemonic and thus totalising human and more-than-human health systems and approach, the special issue acknowledges, situates and authorises broader visions and epistemologies of health and disease. These complementary epistemologies, their words, their movements (Ayu) and their health (Swastya) and balance (Soukya) are contained within indigenous health systems that include Ayurveda and Traditional Chinese Medicine (TCM) amongst a vast array of local health cultures across the globe. In contrast with the narrower approach of medicalisation; integrative, inclusive, plural and sustainable approaches to health involve the respect for a population’s self-reliance in health (the 4th Tier) and the dignity of the Sanskrit word for health, ‘Swastya’ which means ‘being rooted within’. These perspective and epistemologies will help to create a vision for health and health systems that encourage integration through the dignity of the individual (Atmasnman/Anubhuti), respect for the other (Pratiksa/Adara), trust in community (Nyasa) and the creation of systems of equity (Samata) and social justice for all (Nyaya).

在这篇关于《J-AIM》特刊 "健康的整合方法 "的评论中,我们主张以多元化的健康叙事来平衡和重新连接人类与其环境,以促进健康和福祉文化的更新。我们的内部和外部生态系统与多元健康系统的整合需要 "运动 "和 "变革",本特刊提供了从多个学科角度研究人类、非人类、动物和植物与临床试验、个人和群体研究以及健康系统的整合与健康的论文。所有这些视角都为绘制气候紧急时期健康、疾病和福祉方面的整合方法提供了新的视角。为了改善生物医学和生物制药行业 "生命医学化 "的霸权,从而改善人类和超人类健康系统和方法,本特刊承认、定位并授权更广泛的健康和疾病观点和认识论。这些互补的认识论、它们的文字、它们的运动(Ayu)以及它们的健康(Swastya)和平衡(Soukya)都包含在本土的健康体系中,其中包括阿育吠陀和传统中医(TCM),以及全球各地大量的本土健康文化。与狭隘的医学化方法相比,综合、包容、多元和可持续的健康方法涉及尊重民众在健康方面的自力更生(第四层)以及梵语 "Swastya"(意为 "扎根于内心")中健康一词的尊严。这些观点和认识论将有助于为卫生和卫生系统创造一个愿景,通过个人尊严(Atmasnman/Anubhuti)、对他人的尊重(Pratiksa/Adara)、对社区的信任(Nyasa)以及为所有人建立公平(Samata)和社会正义(Nyaya)的系统,鼓励一体化。
{"title":"The importance of epistemology and translation for health and integration: A commentary on the special issue ‘Integrative approaches to health’","authors":"John DH. Porter ,&nbsp;Andrea Núñez Casal ,&nbsp;Coll de Lima Hutchison ,&nbsp;Mahesh Madhav Mathpati ,&nbsp;The Kshoba Group","doi":"10.1016/j.jaim.2024.100924","DOIUrl":"10.1016/j.jaim.2024.100924","url":null,"abstract":"<div><p>In this commentary on the J-AIM Special Issue 'Integrative Approaches to Health', we argue for plural narratives of health to balance and to reconnect human populations with their environments, to foster a renewed culture of health and wellbeing. Integration of our inner and outer ecosystems with pluralistic health systems requires ‘movement’ and ‘change’ and the special issue provides papers on integration and health from multiple disciplinary perspectives that study humans, non-human, animals, and plants in relation to clinical trials, individual and population studies and health systems. All these perspectives provide new insights to map integrative approaches in health, illness and wellbeing in times of the climate emergency.</p><p>To ameliorate the biomedical and biopharmaceutical industries 'medicalisation of life' as the hegemonic and thus totalising human and more-than-human health systems and approach, the special issue acknowledges, situates and authorises broader visions and epistemologies of health and disease. These complementary epistemologies, their words, their movements <em>(Ayu</em>) and their health (<em>Swastya</em>) and balance (<em>Soukya</em>) are contained within indigenous health systems that include Ayurveda and Traditional Chinese Medicine (TCM) amongst a vast array of local health cultures across the globe. In contrast with the narrower approach of medicalisation; integrative, inclusive, plural and sustainable approaches to health involve the respect for a population’s self-reliance in health (the 4<sup>th</sup> Tier) and the dignity of the Sanskrit word for health, ‘Swastya’ which means ‘being rooted within’. These perspective and epistemologies will help to create a vision for health and health systems that encourage integration through the dignity of the individual (<em>Atmasnman</em>/<em>Anubhuti</em>), respect for the other (<em>Pratiksa/Adara</em>), trust in community (<em>Nyasa</em>) and the creation of systems of equity (<em>Samata</em>) and social justice for all (<em>Nyaya</em>).</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 3","pages":"Article 100924"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000391/pdfft?md5=81223b1a1326f0c73c9f3ff7b6bdbf8d&pid=1-s2.0-S0975947624000391-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141186092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda management for acute upper limb ischemia - a case report 阿育吠陀疗法治疗急性上肢缺血--病例报告
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-03-01 DOI: 10.1016/j.jaim.2024.100895
Sarvesh Kumar Singh , Kshipra Rajoria , Sanjeev Sharma

Acute upper limb ischemia (AULI) is a medical and surgical emergency involving sudden decrease in limb perfusion resulting in threat for limb viability. A 52 years old male patient was suffered from AULI. He had the complaints of numbness and pain in left upper limb, headache and pale discoloration of left-hand fingers and acute onset left upper extremity weakness.The Ayurveda diagnosis was considered as Vatarakta. He was advised oral medications - Kaishor guggulu in the dose of 750 mg twice a day with Jwarhar kashaya 40 ml twice a day, Ashwagandha Churna 3 g, Guduchi churna1g, Shatavari churna 2 g, Chopchini churna 1 g with milk twice a day, Shilajatwadi loha 500 mg and Mahavatvidhvansana rasa 250 mg twice a day with honey. All these medications were continued for 12 months. Two courses of Mustadi yapana basti (medicated enema enriched with milk) and Shalishastika pinda swedana (a specific type of sudation with a poultice of rice bolus) and Nasya (nasal therapy) with Shadabindu oil were given. Initial computed tomography (CT) angiogram revealed the abrupt cutoff of the left brachial artery in distal part due to hypodense lesion (thrombus) in the lumen while after 12 months of treatment CT angiogram revealed 70–80 % luminal narrowing in proximal part of left ulnar artery. It suggests the revascularization of left ulnar artery. All the symptoms of AULI were also resolved. We report a unique case of AULI managed with Ayurvedic interventions

急性上肢缺血(AULI)是一种内外科急症,涉及肢体灌注突然减少,导致肢体存活受到威胁。一名 52 岁的男性患者患有急性上肢缺血。他的主诉是左上肢麻木和疼痛、头痛、左手手指苍白变色以及急性发作的左上肢无力。医生建议他口服药物--Kaishor guggulu,剂量为 750 毫克,每天两次;Jwarhar kashaya,剂量为 40 毫升,每天两次;Ashwagandha Churna,剂量为 3 克;Guduchi churna,剂量为 1 克;Shatavari churna,剂量为 2 克;Chopchini churna,剂量为 1 克,加牛奶,每天两次;Shilajatwadi loha,剂量为 500 毫克;Mahavatvidhvansana rasa,剂量为 250 毫克,加蜂蜜,每天两次。所有这些药物都持续服用了 12 个月。此外,患者还接受了两个疗程的 Mustadi yapana basti(牛奶药物灌肠)和 Shalishastika pinda swedana(一种特殊的大米药膏浸泡疗法),以及使用 Shadabindu 油的 Nasya(鼻腔疗法)。最初的计算机断层扫描(CT)血管造影显示,左肱动脉远端由于管腔内的低密度病变(血栓)而突然断流,而在治疗 12 个月后,CT 血管造影显示左尺动脉近端管腔狭窄了 70-80 %。这表明左尺桡动脉已重新血管化。AULI的所有症状也都得到了缓解。我们报告了一例采用阿育吠陀疗法治疗的独特的 AULI 病例
{"title":"Ayurveda management for acute upper limb ischemia - a case report","authors":"Sarvesh Kumar Singh ,&nbsp;Kshipra Rajoria ,&nbsp;Sanjeev Sharma","doi":"10.1016/j.jaim.2024.100895","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100895","url":null,"abstract":"<div><p>Acute upper limb ischemia (AULI) is a medical and surgical emergency involving sudden decrease in limb perfusion resulting in threat for limb viability. A 52 years old male patient was suffered from AULI. He had the complaints of numbness and pain in left upper limb, headache and pale discoloration of left-hand fingers and acute onset left upper extremity weakness.The Ayurveda diagnosis was considered as <em>Vatarakta.</em> He was advised oral medications - <em>Kaishor guggulu</em> in the dose of 750 mg twice a day with <em>Jwarhar kashaya</em> 40 ml twice a day, <em>Ashwagandha Churna</em> 3 g, <em>Guduchi churna</em>1g, <em>Shatavari churna</em> 2 g, <em>Chopchini churna</em> 1 g with milk twice a day, <em>Shilajatwadi loha</em> 500 mg and <em>Mahavatvidhvansana rasa</em> 250 mg twice a day with honey. All these medications were continued for 12 months. Two courses of <em>Mustadi yapana basti</em> (medicated enema enriched with milk) and <em>Shalishastika pinda swedana</em> (a specific type of sudation with a poultice of rice bolus) and <em>Nasya</em> (nasal therapy) with <em>Shadabindu</em> oil were given. Initial computed tomography (CT) angiogram revealed the abrupt cutoff of the left brachial artery in distal part due to hypodense lesion (thrombus) in the lumen while after 12 months of treatment CT angiogram revealed 70–80 % luminal narrowing in proximal part of left ulnar artery. It suggests the revascularization of left ulnar artery. All the symptoms of AULI were also resolved. We report a unique case of AULI managed with Ayurvedic interventions</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100895"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S097594762400010X/pdfft?md5=f32fa9097ab43240a5ba7a3f953682e5&pid=1-s2.0-S097594762400010X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140290275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of reconstituted, lyophilized cold aqueous extract of Aloe vera on human whole blood clotting time - A pilot study 重组冻干芦荟冷水提取物对人体全血凝结时间的影响--一项试点研究
IF 2.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-03-01 DOI: 10.1016/j.jaim.2024.100887
Deena Susie Melenshia , Soosai Manickam Amirtham , Grace Rebekah , Elizabeth Vinod , Upasana Kachroo
{"title":"Effect of reconstituted, lyophilized cold aqueous extract of Aloe vera on human whole blood clotting time - A pilot study","authors":"Deena Susie Melenshia ,&nbsp;Soosai Manickam Amirtham ,&nbsp;Grace Rebekah ,&nbsp;Elizabeth Vinod ,&nbsp;Upasana Kachroo","doi":"10.1016/j.jaim.2024.100887","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100887","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100887"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000020/pdfft?md5=13dc69cf5dfb4424fade6c056e93d76d&pid=1-s2.0-S0975947624000020-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140113310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1